The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

Neuroscience

Volumn 95, Issue 2, 1999, Pages 425-432

  Mirza, B ^a   Hadberg, H ^a   Thomsen, P ^a   Moos, T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ferritin; Glia; Inflammation; Iron; Metallothionein; Neurodegeneration

Indexed keywords

FERRITIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IRON; METALLOTHIONEIN;

ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOREACTIVITY; INFLAMMATION; MORPHOLOGY; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ASTROCYTES; FERRITINS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; IRON; METALLOTHIONEIN; MICROGLIA; NERVE DEGENERATION; NEURITIS; OLIGODENDROGLIA; OXIDATIVE STRESS; PARKINSON DISEASE; PUTAMEN; RECEPTORS, COMPLEMENT; SUBSTANTIA NIGRA;

EID: 0032738677     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00455-8     Document Type: Article

References (55)

1. Anglade P., Vyas S., Hirsch E.C., Agid Y. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol. Histopathol. 12:1997;603-610.
2. Aschner M. Metallothionein (MT) isoforms in the central nervous system (CNS): regional and cell-specific distribution and potential functions as an antioxidant. Neurotoxicology. 19:1998;653-660.
3. Banati R.B., Daniel S.E., Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13:1998;221-227.
4. Batchelor P.E., Liberatore G.T., Wong J.Y., Porritt M.J., Frerichs F., Donnan G.A., Howells D.W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19:1999;1708-1716.
5. Beach T.G., Walker R., McGeer E.G. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia. 2:1989;420-436.
6. Benkovic S.A., Connor J.R. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J. comp. Neurol. 338:1993;97-113.
7. Blaauwgeers H.G., Sillevis Smitt P.A., De Jong J.M., Troost D. Distribution of metallothionein in the human central nervous system. Glia. 8:1993;62-70.
8. Blaauwgeers H.G., Sillevis Smitt P.A., de Jong J.M., Troost D. Localization of metallothionein in the mammalian central nervous system. Biol. Signals. 3:1994;181-187.
9. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 29:1995;17-20.
10. Cassarino D.S., Bennett J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Rev. 29:1999;1-25.
11. Connor J.R., Boeshore K.L., Benkovic S.A., Menzies S.L. Isoforms of ferritin have a specific cellular distribution in the brain. J. Neurosci. Res. 37:1994;461-465.
12. Connor J.R., Snyder B.S., Arosio P., Loeffler D.A., LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65:1995;717-724.
13. Connor J.R., Menzies S.L., St Martin S.M., Mufson E.J. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27:1990;595-611.
14. Dahl D., Bignami A. Heterogeneity of the glial fibrillary acidic protein in gliosed human brains. J. neurol. Sci. 23:1974;551-563.
15. Damier P., Hirsch E.C., Zhang P., Agid Y., Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience. 52:1993;1-6.
16. De la Monte S.M., Ho D.D., Schooley R.T., Hirsch M.S., Richardson E.P. Jr. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology. 37:1987;562-569.
17. De la Monte S.M., Wells S.E., Hedley-Whyte T., Growdon J.H. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann. Neurol. 26:1989;309-320.
18. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 114:1991;1953-1975.
19. Dexter D.T., Sian J., Rose S., Hindmarsh J.G., Mann V.M., Cooper J.M., Wells F.R., Daniel S.E., Lees A.J., Schapira A.H. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35:1994;38-44.
20. Duguid J.R., Bohmont C.W., Liu N.G., Tourtellotte W.W. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 86:1989;7260-7264.
21. Eddleston M., Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
22. Focht S.J., Snyder B.S., Beard J.L., Van Gelder W., Williams L.R., Connor J.R. Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains. Neuroscience. 79:1997;255-261.
23. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cells of the brain. Brain Res. Rev. 20:1995;269-287.
24. Gordon M.N., Schreier W.A., Ou X., Holcomb L.A., Morgan D.G. Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J. comp. Neurol. 388:1997;106-119.
25. Graeber M.B., Bise K., Mehraein P. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropath. appl. Neurobiol. 20:1994;406-408.
26. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
27. Hansen T.M., Nielsen H., Bernth N., Moos T. Expression and distribution of ferritin protein and subunit mRNAs in normal and iron-deficient rats. Molec. Brain Res. 65:1999;186-197.
28. Ho A., Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J. Neurosci. 18:1998;5614-5629.
29. Hussain S., Slikker W. Jr, Ali S.F. Role of metallothionein and other antioxidants in scavenging superoxide radicals and their possible role in neuroprotection. Neurochem. Int. 29:1996;145-152.
30. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord., Suppl. 13:1998;24-34.
31. Kaneko Y., Kitamoto T., Tateishi J., Yamaguchi K. Ferritin immunohistochemistry as a marker for microglia. Acta neuropath. 79:1989;129-136.
32. Kohutnicka M., Lewandowska E., Kurkowska-Jastrzebska I., Czlonkowski A., Czlonkowska A. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology. 39:1998;167-180.
33. Kordower J.H., Styren S., Clarke M., DeKosky S.T., Olanow C.W., Freeman T.B. Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell. Transplant. 6:1997;213-219.
34. Kushner P.D., Stephenson D.T., Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J. Neuropath. exp. Neurol. 50:1991;263-277.
35. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 39:1990;151-170.
36. Lazo J.S., Kondo Y., Dellapiazza D., Michalska A.E., Choo K.H., Pitt B.R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J. biol. Chem. 270:1995;5506-5510.
37. Ling Z.D., Potter E.D., Lipton J.W., Carvey P.M. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Expl Neurol. 149:1998;411-423.
38. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
39. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
40. Milligan C.E., Levitt P., Cunningham T.J. Brain macrophages and microglia respond differently to lesions of the developing and adult visual system. J. comp. Neurol. 314:1991;136-146.
41. Mogi M., Harada M., Kondo T., Mizuno Y., Narabayashi H., Riederer P., Nagatsu T. Bcl-2 protein is increased in the brain from parkinsonian patients. Neurosci. Lett. 215:1996;137-139.
42. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile Parkinsonism and Parkinson's disease. Neurosci. Lett. 14:1996;13-16.
43. Moos T., Høyer P.E. Detection of plasma proteins in CNS neurons: conspicuous influence of tissue-processing parameters and the utilization of serum for blocking nonspecific reactions. J. Histochem. Cytochem. 44:1996;591-603.
44. Ochi T., Otsuka F., Takashshi K., Ohsawa M. Glutathione and metallothionein as cellular defence against cadmium toxicity in cultured Chinese hamster cells. Chem. Biol. Interact. 65:1988;1-14.
45. Olakanmi O., Stokes J.B., Britigan B.E. Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages. J. Immun. 153:1994;2691-2703.
46. Rojas P., Cerutis D.R., Happe H.K., Murrin L.C., Hao R., Pfeiffer R.F., Ebadi M. 6-Hydroxydopamine-mediated induction of rat brain metallothionein I mRNA. Neurotoxicology. 17:1996;323-334.
47. Rojas P., Rios C. Metallothionein inducers protect against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice. Neurochem. Res. 22:1997;17-22.
48. Schipper H.M., Liberman A., Stopa E.G. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Expl Neurol. 150:1998;60-68.
49. Schwarz M.A., Lazo J.S., Yalowich J.C., Reynolds I., Kagan V.E., Tyurin V., Kim Y.M., Watkins S.C., Pitt B.R. Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J. biol. Chem. 269:1994;15,238-15,243.
50. Schwarz S.C., Seufferlein T., Liptay S., Schmid R.M., Kasischke K., Foster O.J., Daniel S., Schwarz J. Microglial activation in multiple system atrophy: a potential role for NF-kappaB/rel proteins. NeuroReport. 9:1998;3029-3032.
51. Sillevis Smitt P.A., Blaauwgeers H.G., Troost D., de Jong J.M. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 144:1992;107-110.
52. Stoll G., Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58:1999;233-247.
53. Tompkins M.M., Basgall E.J., Zamrini E., William D.H. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurones. Am. J. Path. 150:1997;119-131.
54. Walker D.G., Beach T.G., Xu R., Lile J., Beck K.D., McGeer E.G., McGeer P.L. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease. Brain Res. 792:1998;207-217.
55. Wullner U., Kornhuber J., Weller M., Schulz J.B., Loschmann P.A., Riederer P., Klockgether T. Cell death and apoptosis regulating proteins in Parkinson's disease - a cautionary note. Acta neuropath. 97:1999;408-412.